GNFT
Genfit S.A.NASDAQHealthcare$8.95+4.07%ClosedMarket Cap: $445.7M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
8.19
P/S
9.54
EV/EBITDA
-19.86
DCF Value
$-58.51
FCF Yield
-1.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
93.1%
Operating Margin
-61.8%
Net Margin
-85.9%
ROE
-63.7%
ROA
-17.9%
ROIC
-13.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $35.5M | 100.0% | $76.0K | $-10.0M | $-0.20 | — |
| Q4 2024 | $5.9M | 109.5% | $-27.9M | $-28.8M | $-0.58 | — |
| FY 2024 | $67.0M | 99.6% | $3.3M | $1.5M | $0.03 | — |
| Q2 2024 | $61.1M | 100.0% | $31.2M | $30.3M | $0.50 | — |
| Q4 2023 | $14.3M | 135.8% | $-2.8M | $-8.0M | $-0.16 | — |
| FY 2023 | $28.6M | 98.8% | $-26.6M | $-28.9M | $-0.58 | — |
| Q2 2023 | $11.5M | 131.6% | $-23.7M | $-20.9M | $-0.42 | — |
| Q4 2022 | $6.1M | 100.0% | $0.00 | $0.00 | $0.00 | — |
| FY 2022 | $20.2M | 98.8% | $-27.3M | $-23.7M | $-0.48 | — |
| Q2 2022 | $8.8M | 138.1% | $-17.5M | $-10.4M | $-0.21 | — |
| Q4 2021 | $80.1M | 102.6% | $58.7M | $58.2M | $1.02 | — |
| FY 2021 | $80.1M | 99.8% | $31.8M | $67.3M | $1.23 | — |